U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07005999) titled 'Interventional Ablation for Early-stage Lung Cancer' on May 19.
Brief Summary: What is this study about? This clinical trial aims to compare two treatments for high-risk lung nodules or early-stage lung cancer: interventional ablation (a minimally invasive procedure that destroys tumors with heat or cold) and surgical resection (surgery to remove the tumor). The goal is to determine if ablation is as safe and effective as surgery while preserving more lung function.
Why is this important? Lung cancer is a leading cause of cancer deaths worldwide. Early detection improves survival, but surgery can damage lung function.
Ablation (e.g...